NewsPfizer Enters a ~$6.05B Exclusive Licensing Agreement with 3SBio for SSGJ-707ByRidhi RastogiMay 20, 20250Comments
VIEWPOINTSAdvancing Lupus Research: Devon Kelly from Lupus Nexus in a Stimulating Conversation with PharmaShotsBySaurabh ChaubeyMay 19, 20251Comment
NewsIonis Reveals Topline P-III (ESSENCE) Trial Data of Olezarsen for Moderate HypertriglyceridemiaByRidhi RastogiMay 19, 20250Comments
NewsApnimed Reports Topline P-III (SynAIRgy) Trial Data of AD109 for Obstructive Sleep Apnea (OSA)ByRidhi RastogiMay 19, 20250Comments
NewsSkye Bioscience Enters a Formulation Development Agreement with Arecor Therapeutics for NimacimabByRidhi RastogiMay 19, 20250Comments
NewsBioMarin Pharmaceutical to Acquire Inozyme Pharma for ~$270M, Strengthening its Enzyme Therapies PortfolioByRidhi RastogiMay 19, 20250Comments
NewsGSK Receives the MHLW’s Approval for Blenrep (Belantamab Mafodotin) Regimens to Treat R/R Multiple MyelomaByRidhi RastogiMay 19, 20250Comments
NewsBMS’ Opdivo Receives the EC’s Approval as a Perioperative Treatment of Resectable NSCLCByRidhi RastogiMay 19, 20250Comments